Capitol Clarity / Firms / Apotex Corp.

Apotex Corp.

Apotex Corp. lobbies on its own behalf. For Q3 2026 it reported $220K across 1 client report and lists 1 lobbyist across its filings. Issues include Manufacturing and Trade (domestic/foreign).

Clients, Q3 2026

ClientReportedIssues
APOTEX CORP.$220KManufacturing, Trade (domestic/foreign)

By year

YearReportedClients
2026$1.68M1
2025$1.68M1

Lobbyists listed

Amounts are the filer's good-faith estimates, per report, and cannot be split by issue. See the Capitol Clarity rankings and method.